type 2 diabetes

Top 3 new drug approvalsHere are 3 of the top new drug approvals in late December and early January.
Top 5 pipeline drugs for 2018
Top 5 pipeline drugs for 2018New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
New Research Suggests the Immune System Could Aid In Regulating Insulin in Type 2 DiabetesThe immune system could play a beneficial role in regulating insulin, according to a study from Switzerland.
Riomet (Metformin Hydrochloride Oral Solution) Recalled
Riomet (Metformin Hydrochloride Oral Solution) RecalledSamples of the diabetes medication were contaminated.
Late Menopause May Link to Reduced Risk of DiabetesA prospective study found a reduced risk of developing diabetes in women the later they entered menopause.
Game-changing hep B vaccine gets FDA nodThe first 2-dose hepatitis B vaccine, which was recently approved by FDA, is expected to be commercially available in early 2018.
Five technologies to transform healthcareFive healthcare tech trends that will make chronic care management a part of patients’ daily lives.
FDA okays unique injectable for type 2 diabeticsFDA approved a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.
New diabetes drug set to rival TrulicityIf it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).
Blockbuster diabetes drug earns heart indication
Blockbuster diabetes drug earns heart indicationA top-selling diabetes drug has gained a cardiovascular indication from FDA.